User menu

Pediatric HIV: new opportunities to treat children.

Bibliographic reference Van der Linden, Dimitri ; Callens, Steven ; Brichard, Bénédicte ; Colebunders, Robert. Pediatric HIV: new opportunities to treat children.. In: Expert Opinion on Pharmacotherapy, Vol. 10, no. 11, p. 1783-1791 (2009)
Permanent URL http://hdl.handle.net/2078.1/27707
  1. Goetghebuer Tessa, Haelterman Edwige, Marvillet Isabelle, Barlow Patricia, Hainaut Marc, Salameh Assaad, Ciardelli Roberta, Gerard Michele, Levy Jack, Vertical transmission of HIV in Belgium: a 1986–2002 retrospective analysis, 10.1007/s00431-008-0717-y
  2. de Martino Maurizio, Reduction in Mortality With Availability of Antiretroviral Therapy for Children With Perinatal HIV-1 Infection, 10.1001/jama.284.2.190
  3. Judd A., Doerholt K., Tookey P. A., Sharland M., Riordan A., Menson E., Novelli V., Lyall E. G. H., Masters J., Tudor-Williams G., Duong T., Gibb D. M., , Morbidity, Mortality, and Response to Treatment by Children in the United Kingdom and Ireland with Perinatally Acquired HIV Infection during 1996-2006: Planning for Teenage and Adult Care, 10.1086/521167
  4. George Erik, Noël Francine, Bois Gyrlande, Cassagnol Rachelle, Estavien Louise, Rouzier Patricia De Matteis, Verdier Rose I., Johnson Warren D., Pape Jean W., Fitzgerald Daniel W., Wright Peter F., Antiretroviral Therapy for HIV‐1–Infected Children in Haiti, 10.1086/514823
  5. Janssens B., Raleigh B., Soeung S., Akao K., Te V., Gupta J., Chhy Vun M., Ford N., Nouhin J., Nerrienet E., Effectiveness of Highly Active Antiretroviral Therapy in HIV-Positive Children: Evaluation at 12 Months in a Routine Program in Cambodia, 10.1542/peds.2006-3503
  6. Kamya Moses R, Mayanja-Kizza Harriet, Kambugu Andrew, Bakeera-Kitaka Sabrina, Semitala Fred, Mwebaze-Songa Patricia, Castelnuovo Barbara, Schaefer Petra, Spacek Lisa A, Gasasira Anne F, Katabira Elly, Colebunders Robert, Quinn Thomas C, Ronald Allan, Thomas David L, Kekitiinwa Adeodata, Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy : , 10.1097/qai.0b013e31814278c0
  7. Kiboneka Andrew, Wangisi Jonathan, Nabiryo Christine, Tembe Juliet, Kusemererwa Sylvia, Olupot-Olupot Peter, Joffres Michel, Anema Aranka, Cooper Curtis L, Montaner Julio S, Mills Edward J, Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda : , 10.1097/qad.0b013e328318f148
  8. Puthanakit Thanyawee, Aurpibul Linda, Oberdorfer Peninnah, Akarathum Noppadon, Kanjanavanit Suparat, Wannarit Pornphun, Sirisanthana Thira, Sirisanthana Virat, SUSTAINED IMMUNOLOGIC AND VIROLOGIC EFFICACY AFTER FOUR YEARS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED CHILDREN IN THAILAND : , 10.1097/inf.0b013e318125720a
  9. Reddi Anand, Leeper Sarah C, Grobler Anneke C, Geddes Rosemary, France K Holly, Dorse Gillian L, Vlok Willem J, Mntambo Mbali, Thomas Monty, Nixon Kristy, Holst Helga L, Karim Quarraisha Abdool, Rollins Nigel C, Coovadia Hoosen M, Giddy Janet, Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa, 10.1186/1471-2431-7-13
  10. Callens Steven F. J., Shabani Nicole, Lusiama Jean, Lelo Patricia, Kitetele Faustin, Colebunders Robert, Gizlice Ziya, Edmonds Andrew, Van Rie Annelies, Behets Frieda, Mortality and Associated Factors After Initiation of Pediatric Antiretroviral Treatment in the Democratic Republic of the Congo : , 10.1097/inf.0b013e318184eeb9
  11. Fiscus S. A., Wiener J., Abrams E. J., Bulterys M., Cachafeiro A., Respess R. A., Ultrasensitive p24 Antigen Assay for Diagnosis of Perinatal Human Immunodeficiency Virus Type 1 Infection, 10.1128/jcm.00813-07
  12. Inwani Irene, Mbori-Ngacha Dorothy, Nduati Ruth, Obimbo Elizabeth, Wamalwa Dalton, John-Stewart Grace, Farquhar Carey, Performance of Clinical Algorithms for HIV-1 Diagnosis and Antiretroviral Initiation Among HIV-1-Exposed Children Aged Less Than 18 Months in Kenya : , 10.1097/qai.0b013e318198a8a4
  13. Blanche Stéphane, Newell Marie-Louise, Mayaux Marie-Jeanne, Dunn David T., Teglas Jean Paul, Rouzioux Christine, Peckham Catherine S., Morbidity and Mortality in European Children Vertically Infected by HIV-1 : The French Pediatric HIV Infection Study Group and European Collaborative Study, 10.1097/00042560-199704150-00008
  14. , Fluctuations in Symptoms in Human Immunodeficiency Virus-Infected Children: The First 10 Years of Life, 10.1542/peds.108.1.116
  15. Highly active antiretroviral therapy started in infants under 3 months of age : 72-week follow-up for CD4 cell count, viral load and drug resistance outcome, 10.1097/00002030-200401230-00013
  16. Chiappini Elena, Galli Luisa, Tovo Pier-Angelo, Gabiano Clara, Gattinara Guido Castelli, Guarino Alfredo, Baddato Raffaele, Giaquinto Carlo, Lisi Catiuscia, de Martino Maurizio, Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. : , 10.1097/01.aids.0000200529.64113.3e
  17. Faye Albert, Le Chenadec Jerôme, Dollfus Catherine, Thuret Isabelle, Douard Danièle, Firtion Ghislaine, Lachassinne Eric, Levine Martine, Nicolas Joelle, Monpoux Fabrice, Tricoire Joelle, Rouzioux Christine, Tardieu Marc, Mayaux Marie Jeanne, Blanche Stéphane, , Early versus Deferred Antiretroviral Multidrug Therapy in Infants Infected with HIV Type 1, 10.1086/425739
  18. Van der Linden Dimitri, Hainaut Marc, Goetghebuer Tessa, Haelterman Edwige, Schmitz V??ronique, Maes Philip, Peltier Alexandra, Levy Jack, EFFECTIVENESS OF EARLY INITIATION OF PROTEASE INHIBITOR-SPARING ANTIRETROVIRAL REGIMEN IN HUMAN IMMUNODEFICIENCY VIRUS-1 VERTICALLY INFECTED INFANTS : , 10.1097/01.inf.0000258626.34984.eb
  19. Goetghebuer Tessa, Haelterman Edwige, Le Chenadec Jerome, Dollfus Catherine, Gibb Diana, Judd Ali, Green Hannah, Galli Luisa, Ramos Jose Tomas, Giaquinto Carlo, Warszawski Josiane, Levy Jack, Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants : , 10.1097/qad.0b013e328326ca37
  20. Violari Avy, Cotton Mark F., Gibb Diana M., Babiker Abdel G., Steyn Jan, Madhi Shabir A., Jean-Philippe Patrick, McIntyre James A., Early Antiretroviral Therapy and Mortality among HIV-Infected Infants, 10.1056/nejmoa0800971
  21. Giaquinto Carlo, Rampon Osvalda, Penazzato Martina, Fregonese Federica, De Rossi Anita, D??Elia Ruggiero, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors in Children : , 10.2165/00044011-200727080-00001
  22. Sharland M, Blanche S, Castelli G, Ramos J, Gibb DM, , PENTA guidelines for the use of antiretroviral therapy, 2004, 10.1111/j.1468-1293.2004.00227.x
  23. Purdy Julia B., Gafni Rachel I., Reynolds James C., Zeichner Steven, Hazra Rohan, Decreased Bone Mineral Density with Off-Label Use of Tenofovir in Children and Adolescents Infected with Human Immunodeficiency Virus, 10.1016/j.jpeds.2007.12.020
  24. Hazra R., Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy for Pediatric HIV Infection, 10.1542/peds.2005-0975
  25. Riordan Andrew, Judd Ali, Boyd Katherine, Cliff David, Doerholt Katia, Lyall Hermione, Menson Esse, Butler Karina, Gibb Di, Tenofovir Use in Human Immunodeficiency Virus-1–Infected Children in the United Kingdom and Ireland : , 10.1097/inf.0b013e31818c8d2c
  26. Chintu Chifumbe, Tuberculosis and human immunodeficiency virus co-infection in children: management challenges, 10.1016/j.prrv.2007.05.003
  27. Chadwick Ellen G, Capparelli Edmund V, Yogev Ram, Pinto Jorge A, Robbins Brian, Rodman John H, Chen Jie, Palumbo Paul, Serchuck Leslie, Smith Elizabeth, Hughes Michael, Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results : , 10.1097/qad.0b013e3282f2be1d
  28. Chadwick Ellen Gould, Pinto Jorge, Yogev Ram, Alvero Carmelita G., Hughes Michael D., Palumbo Paul, Robbins Brian, Hazra Rohan, Serchuck Leslie, Heckman Barbara E., Purdue Lynette, Browning Renee, Luzuriaga Katherine, Rodman John, Capparelli Edmund, Early Initiation of Lopinavir/Ritonavir in Infants Less Than 6 Weeks of Age : Pharmacokinetics and 24-Week Safety and Efficacy, 10.1097/inf.0b013e31818cc053
  29. van der Flier, Antivir Ther, 13, 1087 (2008)
  30. CHURCH JOSEPH A., CUNNINGHAM COLEEN, HUGHES MICHAEL, PALUMBO PAUL, MOFENSON LYNNE M., DELORA PATRICIA, SMITH ELIZABETH, WIZNIA ANDREW, PURDUE LYNETTE, HAWKINS ELIZABETH, SISTA PRAKASH, Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children : , 10.1097/00006454-200207000-00010
  31. Bellibas, Pediatr Infect Dis J, 23, 1137 (2004)
  32. Zhang Xiaoping, Lin Tiffany, Bertasso Anne, Evans Claire, Dorr Albert, Kolis Stanley J., Salgo Miklos, Patel Indravadan, Population Pharmacokinetics of Enfuvirtide in HIV-1-Infected Pediatric Patients Over 48 Weeks of Treatment, 10.1177/0091270006299089
  33. Lʼhomme Rafaëlla FA, Kabamba Desiré, Ewings Fiona M, Mulenga Veronica, Kankasa Chipepo, Thomason Margaret J, Walker A Sarah, Chintu Chifumbe, Burger David M, Gibb Diana M, Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets : , 10.1097/qad.0b013e3282f4a208
  34. Chokephaibulkit Kulkanya, Plipat Nottasorn, Cressey Tim R, Frederix Koen, Phongsamart Wanatpreeya, Capparelli Edmund, Kolladarungkri Teera, Vanprapar Nirun, Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine : , 10.1097/01.aids.0000183625.97170.59
  35. Ellis, Antivir Ther, 12, 253 (2007)
  36. Santoro, New Microbiol, 29, 89 (2006)
  37. MMWR, 43, 1 (1994)